LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for levopropoxyphene napsylate anhydrous and what is the scope of patent protection?
Levopropoxyphene napsylate anhydrous
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Patent Applications: | 9 |
DailyMed Link: | LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS at DailyMed |
Medical Subject Heading (MeSH) Categories for LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
US Patents and Regulatory Information for LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | NOVRAD | levopropoxyphene napsylate anhydrous | CAPSULE;ORAL | 012928-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | NOVRAD | levopropoxyphene napsylate anhydrous | SUSPENSION;ORAL | 012928-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | NOVRAD | levopropoxyphene napsylate anhydrous | CAPSULE;ORAL | 012928-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |